Results
71,123 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO |  SUPNSUPERNUS PHARMACEUTICALS, INC.Other acquisition or disposition | J | — 15.0K sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 15.0K sh |
| Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,847 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Watkins PhilipEVP, Head of Corp Devel & IR |  CUBICustomers Bancorp, Inc.Option exercise | M | $57K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 30.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 250.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 18.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Merriman Dwight ADirector |  MDBMongoDB, Inc.Open-market sale · 10b5-1 plan | SELL | $1.70M 4,846 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Bhatt Padmanabh P.Sr. VP of IP, CSO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Woods Todd CharlesChief Commercial Officer |  WAYWaystar Holding Corp.Tax withholding | F | $111K 4,042 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Open-market sale · 10b5-1 plan | SELL | $819K 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 12.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $23K 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,293 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 27.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Norwood Anthony REVP & CHRO |  SAIASAIA INCTax withholding | F | $55K 155 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 400.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,905 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,036 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 10.2K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 9,305 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | DeLucchi Graziano Angelo Giovanni PasquinoDirector |  USGOU.S. GoldMining Inc.Grant or award | A | $57K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Sloan Lindsay LVP & Chief Accounting Officer |  CMCCOMMERCIAL METALS CoGift | G | — 200 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 6,293 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 13.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 40.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 50.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 85.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 14.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,350 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barker BrianDirector |  ACUACME UNITED CORPOption exercise | M | $109K 5,000 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Fenimore Christopher R.EVP Finance CFO |  REGNREGENERON PHARMACEUTICALS, INC.Gift | G | — 15 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $54K 1,200 sh | Nov 4, 2026 traded Nov 2, 2026 |